Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription Articles published in Oncogene Retrieve available abstracts of 157 articles: HTML format

Single Articles

July 2021
1. FAN X, Wang Y, Jiang T, Liu T, et al
   B-Myb accelerates colorectal cancer progression through reciprocal feed-forward transactivation of E2F2.
   Oncogene. 2021 Jul 27. pii: 10.1038/s41388-021-01961.
   PubMed     Abstract available
   
   
   
2. KOBELT D, Perez-Hernandez D, Fleuter C, Dahlmann M, et al
   The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis.
   Oncogene. 2021 Jul 10. pii: 10.1038/s41388-021-01917.
   PubMed     Abstract available
   
   
   
3. RUAN DY, Li T, Wang YN, Meng Q, et al
   FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis.
   Oncogene. 2021 Jul 3. pii: 10.1038/s41388-021-01916.
   PubMed     Abstract available
   
   
   June 2021
4. SUN L, Patai AV, Hogenson TL, Fernandez-Zapico ME, et al
   Irreversible JNK blockade overcomes PD-L1-mediated resistance to chemotherapy in colorectal cancer.
   Oncogene. 2021 Jun 30. pii: 10.1038/s41388-021-01910.
   PubMed     Abstract available
   
   
   
5. ZHAO S, Guan B, Mi Y, Shi D, et al
   LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit.
   Oncogene. 2021 Jun 18. pii: 10.1038/s41388-021-01859.
   PubMed     Abstract available
   
   
   
6. WANG H, Wang X, Zhang H, Deng T, et al
   The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer.
   Oncogene. 2021 Jun 17. pii: 10.1038/s41388-021-01898.
   PubMed     Abstract available
   
   
   
7. MCANDREWS KM, Vazquez-Arreguin K, Kwak C, Sugimoto H, et al
   alphaSMA(+) fibroblasts suppress Lgr5(+) cancer stem cells and restrain colorectal cancer progression.
   Oncogene. 2021 Jun 9. pii: 10.1038/s41388-021-01866.
   PubMed     Abstract available
   
   
   
8. MALKOMES P, Lunger I, Oppermann E, Abou-El-Ardat K, et al
   Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53.
   Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01847.
   PubMed     Abstract available
   
   
   May 2021
9. YOU J, Li J, Ke C, Xiao Y, et al
   Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer.
   Oncogene. 2021 May 28. pii: 10.1038/s41388-021-01839.
   PubMed     Abstract available
   
   
   
10. CHEN J, Na R, Xiao C, Wang X, et al
    The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy.
    Oncogene. 2021 May 14. pii: 10.1038/s41388-021-01815.
    PubMed     Abstract available
    
    
    
11. ZHANG XL, Hu LP, Yang Q, Qin WT, et al
    CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-beta receptors in colorectal cancer.
    Oncogene. 2021 May 13. pii: 10.1038/s41388-021-01827.
    PubMed     Abstract available
    
    
    
12. ZENG K, Chen X, Hu X, Liu X, et al
    Correction: LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
    Oncogene. 2021 May 6. pii: 10.1038/s41388-021-01795.
    PubMed    
    
    
    April 2021
13. LIU J, Huang Z, Chen HN, Qin S, et al
    ZNF37A promotes tumor metastasis through transcriptional control of THSD4/TGF-beta axis in colorectal cancer.
    Oncogene. 2021 Apr 19. pii: 10.1038/s41388-021-01713.
    PubMed     Abstract available
    
    
    
14. XIAO Q, Gan Y, Li Y, Fan L, et al
    MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression.
    Oncogene. 2021 Apr 16. pii: 10.1038/s41388-021-01774.
    PubMed     Abstract available
    
    
    March 2021
15. CHUEH AC, Advani G, Foroutan M, Smith J, et al
    CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation.
    Oncogene. 2021 Mar 25. pii: 10.1038/s41388-021-01755.
    PubMed     Abstract available
    
    
    
16. WESTENDORP F, Karpus ON, Koelink PJ, Vermeulen JLM, et al
    Epithelium-derived Indian Hedgehog restricts stromal expression of ErbB family members that drive colonic tumor cell proliferation.
    Oncogene. 2021;40:1628-1643.
    PubMed     Abstract available
    
    
    February 2021
17. CUI K, Yao S, Zhang H, Zhou M, et al
    Identification of an immune overdrive high-risk subpopulation with aberrant expression of FOXP3 and CTLA4 in colorectal cancer.
    Oncogene. 2021 Feb 24. pii: 10.1038/s41388-021-01677.
    PubMed     Abstract available
    
    
    
18. PENG K, Zhuo M, Li M, Chen Q, et al
    Correction to: Histone demethylase JMJD2D activates HIF1 signaling pathway via multiple mechanisms to promote colorectal cancer glycolysis and progression.
    Oncogene. 2021 Feb 22. pii: 10.1038/s41388-021-01678.
    PubMed    
    
    
    
19. XU H, Liu L, Li W, Zou D, et al
    Correction: Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications.
    Oncogene. 2021 Feb 9. pii: 10.1038/s41388-021-01651.
    PubMed    
    
    
    January 2021
20. YIN XK, Wang YL, Wang F, Feng WX, et al
    PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01617.
    PubMed     Abstract available
    
    
    
21. LI H, Zhao L, Lau YS, Zhang C, et al
    Genome-wide CRISPR screen identifies LGALS2 as an oxidative stress-responsive gene with an inhibitory function on colon tumor growth.
    Oncogene. 2021;40:177-188.
    PubMed     Abstract available
    
    
    
22. GIRONDEL C, Levesque K, Langlois MJ, Pasquin S, et al
    Loss of interleukin-17 receptor D promotes chronic inflammation-associated tumorigenesis.
    Oncogene. 2021;40:452-464.
    PubMed     Abstract available
    
    
    
23. SCHMIDT AK, Pudelko K, Boekenkamp JE, Berger K, et al
    The p53/p73 - p21(CIP1) tumor suppressor axis guards against chromosomal instability by restraining CDK1 in human cancer cells.
    Oncogene. 2021;40:436-451.
    PubMed     Abstract available
    
    
    
24. BALA P, Singh AK, Kavadipula P, Kotapalli V, et al
    Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer.
    Oncogene. 2021;40:863-874.
    PubMed     Abstract available
    
    
    December 2020
25. XU H, Liu L, Li W, Zou D, et al
    Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications.
    Oncogene. 2020 Dec 15. pii: 10.1038/s41388-020-01587.
    PubMed     Abstract available
    
    
    
26. BERGIN CJ, Zouggar A, Haebe JR, Masibag AN, et al
    G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer.
    Oncogene. 2020 Dec 15. pii: 10.1038/s41388-020-01591.
    PubMed     Abstract available
    
    
    
27. SHI C, Yang EJ, Liu Y, Mou PK, et al
    Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression.
    Oncogene. 2020 Dec 8. pii: 10.1038/s41388-020-01580.
    PubMed     Abstract available
    
    
    November 2020
28. BECK M, Baranger M, Moufok-Sadoun A, Bersuder E, et al
    The atypical cadherin MUCDHL antagonizes colon cancer formation and inhibits oncogenic signaling through multiple mechanisms.
    Oncogene. 2020 Nov 13. pii: 10.1038/s41388-020-01546.
    PubMed     Abstract available
    
    
    
29. XU L, Huan L, Guo T, Wu Y, et al
    LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1alpha.
    Oncogene. 2020;39:7005-7018.
    PubMed     Abstract available
    
    
    September 2020
30. PENG K, Zhuo M, Li M, Chen Q, et al
    Histone demethylase JMJD2D activates HIF1 signaling pathway via multiple mechanisms to promote colorectal cancer glycolysis and progression.
    Oncogene. 2020 Sep 28. pii: 10.1038/s41388-020-01483.
    PubMed     Abstract available
    
    
    
31. GAN T, Stevens AT, Xiong X, Wen YA, et al
    Inhibition of protein tyrosine phosphatase receptor type F suppresses Wnt signaling in colorectal cancer.
    Oncogene. 2020 Sep 24. pii: 10.1038/s41388-020-01472.
    PubMed     Abstract available
    
    
    
32. JIN G, Yan M, Liu K, Yao K, et al
    Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer.
    Oncogene. 2020 Sep 22. pii: 10.1038/s41388-020-01467.
    PubMed     Abstract available
    
    
    
33. REISCHMANN N, Andrieux G, Griffin R, Reinheckel T, et al
    BRAF(V600E) drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation.
    Oncogene. 2020;39:6053-6070.
    PubMed     Abstract available
    
    
    August 2020
34. BARTOLOME RA, Pintado-Berninches L, Jaen M, de Los Rios V, et al
    SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166.
    Oncogene. 2020 Aug 15. pii: 10.1038/s41388-020-01419.
    PubMed     Abstract available
    
    
    
35. CAI J, Liu W, Wong CW, Zhu W, et al
    Zinc-finger antiviral protein acts as a tumor suppressor in colorectal cancer.
    Oncogene. 2020 Aug 7. pii: 10.1038/s41388-020-01416.
    PubMed     Abstract available
    
    
    
36. BRAGGIO D, Zewdu A, Londhe P, Yu P, et al
    beta-catenin S45F mutation results in apoptotic resistance.
    Oncogene. 2020;39:5589-5600.
    PubMed     Abstract available
    
    
    July 2020
37. YAN P, Liu J, Zhou R, Lin C, et al
    LASP1 interacts with N-WASP to activate the Arp2/3 complex and facilitate colorectal cancer metastasis by increasing tumour budding and worsening the pattern of invasion.
    Oncogene. 2020 Jul 23. pii: 10.1038/s41388-020-01397.
    PubMed     Abstract available
    
    
    June 2020
38. ZHANG YH, Shi WN, Wu SH, Miao RR, et al
    SphK2 confers 5-fluorouracil resistance to colorectal cancer via upregulating H3K56ac-mediated DPD expression.
    Oncogene. 2020 Jun 16. pii: 10.1038/s41388-020-1352.
    PubMed     Abstract available
    
    
    
39. YI H, Li G, Long Y, Liang W, et al
    Integrative multi-omics analysis of a colon cancer cell line with heterogeneous Wnt activity revealed RUNX2 as an epigenetic regulator of EMT.
    Oncogene. 2020 Jun 13. pii: 10.1038/s41388-020-1351.
    PubMed     Abstract available
    
    
    
40. FONG W, Li Q, Yu J
    Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
    Oncogene. 2020 Jun 8. pii: 10.1038/s41388-020-1341.
    PubMed     Abstract available
    
    
    May 2020
41. ZHU Z, Song J, Guo Y, Huang Z, et al
    LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.
    Oncogene. 2020 May 12. pii: 10.1038/s41388-020-1321.
    PubMed     Abstract available
    
    
    
42. PARK SM, Hwang CY, Choi J, Joung CY, et al
    Feedback analysis identifies a combination target for overcoming adaptive resistance to targeted cancer therapy.
    Oncogene. 2020;39:3803-3820.
    PubMed     Abstract available
    
    
    
43. YU L, Dong L, Li H, Liu Z, et al
    Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis.
    Oncogene. 2020;39:4450-4464.
    PubMed     Abstract available
    
    
    April 2020
44. TIAN Q, Yuan P, Quan C, Li M, et al
    Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer.
    Oncogene. 2020 Apr 1. pii: 10.1038/s41388-020-1262.
    PubMed     Abstract available
    
    
    
45. LI S, Lavrijsen M, Bakker A, Magierowski M, et al
    Commonly observed RNF43 mutations retain functionality in attenuating Wnt/beta-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers.
    Oncogene. 2020;39:3458-3472.
    PubMed     Abstract available
    
    
    
46. ZHUO M, Chen W, Shang S, Guo P, et al
    Inflammation-induced JMJD2D promotes colitis recovery and colon tumorigenesis by activating Hedgehog signaling.
    Oncogene. 2020;39:3336-3353.
    PubMed     Abstract available
    
    
    
47. KATO H, Asamitsu K, Sun W, Kitajima S, et al
    Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.
    Oncogene. 2020;39:3322-3335.
    PubMed     Abstract available
    
    
    March 2020
48. GAO Q, Zhou R, Meng Y, Duan R, et al
    Long noncoding RNA CMPK2 promotes colorectal cancer progression by activating the FUBP3-c-Myc axis.
    Oncogene. 2020 Mar 20. pii: 10.1038/s41388-020-1266.
    PubMed     Abstract available
    
    
    
49. WENZEL J, Rose K, Haghighi EB, Lamprecht C, et al
    Loss of the nuclear Wnt pathway effector TCF7L2 promotes migration and invasion of human colorectal cancer cells.
    Oncogene. 2020 Mar 20. pii: 10.1038/s41388-020-1259.
    PubMed     Abstract available
    
    
    
50. HE Z, Thorrez L, Siegfried G, Meulemans S, et al
    The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer.
    Oncogene. 2020 Mar 6. pii: 10.1038/s41388-020-1238.
    PubMed     Abstract available
    
    
    
51. LI L, Liu J, Xue H, Li C, et al
    A TGF-beta-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.
    Oncogene. 2020;39:2125-2139.
    PubMed     Abstract available
    
    
    February 2020
52. DU F, Li X, Feng W, Qiao C, et al
    SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET.
    Oncogene. 2020 Feb 28. pii: 10.1038/s41388-020-1233.
    PubMed     Abstract available
    
    
    
53. WANG X, Wang Y, Li L, Xue X, et al
    A lncRNA coordinates with Ezh2 to inhibit HIF-1alpha transcription and suppress cancer cell adaption to hypoxia.
    Oncogene. 2020;39:1860-1874.
    PubMed     Abstract available
    
    
    January 2020
54. OUAHOUD S, Voorneveld PW, van der Burg LRA, de Jonge-Muller ESM, et al
    Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancer.
    Oncogene. 2020 Jan 23. pii: 10.1038/s41388-020-1157.
    PubMed     Abstract available
    
    
    December 2019
55. RIPANI P, Delp J, Bode K, Delgado ME, et al
    Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain.
    Oncogene. 2019 Dec 16. pii: 10.1038/s41388-019-1142.
    PubMed     Abstract available
    
    
    
56. ZHOU B, Zong S, Zhong W, Tian Y, et al
    Correction: Interaction between laminin-5gamma2 and integrin beta1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins.
    Oncogene. 2019 Dec 4. pii: 10.1038/s41388-019-1113.
    PubMed     Abstract available
    
    
    
57. KO YS, Bae JA, Kim KY, Kim SJ, et al
    MYO1D binds with kinase domain of the EGFR family to anchor them to plasma membrane before their activation and contributes carcinogenesis.
    Oncogene. 2019;38:7416-7432.
    PubMed     Abstract available
    
    
    November 2019
58. ZHOU B, Zong S, Zhong W, Tian Y, et al
    Interaction between laminin-5gamma2 and integrin beta1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins.
    Oncogene. 2019 Nov 1. pii: 10.1038/s41388-019-1082.
    PubMed     Abstract available
    
    
    
59. SHENG YH, Wong KY, Seim I, Wang R, et al
    MUC13 promotes the development of colitis-associated colorectal tumors via beta-catenin activity.
    Oncogene. 2019;38:7294-7310.
    PubMed     Abstract available
    
    
    
60. KOH XY, Koh XH, Hwang LA, Ferrer FJ, et al
    Therapeutic anti-cancer activity of antibodies targeting sulfhydryl bond constrained epitopes on unglycosylated RON receptor tyrosine kinase.
    Oncogene. 2019;38:7342-7356.
    PubMed     Abstract available
    
    
    October 2019
61. YU CY, Han JX, Zhang J, Jiang P, et al
    A 16q22.1 variant confers susceptibility to colorectal cancer as a distal regulator of ZFP90.
    Oncogene. 2019 Oct 22. pii: 10.1038/s41388-019-1055.
    PubMed     Abstract available
    
    
    
62. LIANG Y, Hou L, Li L, Li L, et al
    Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway.
    Oncogene. 2019 Oct 9. pii: 10.1038/s41388-019-1035.
    PubMed     Abstract available
    
    
    
63. YING Y, Wang Y, Huang X, Sun Y, et al
    Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1.
    Oncogene. 2019 Oct 7. pii: 10.1038/s41388-019-1013.
    PubMed     Abstract available
    
    
    
64. VESCHI V, Mangiapane LR, Nicotra A, Di Franco S, et al
    Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant.
    Oncogene. 2019 Oct 7. pii: 10.1038/s41388-019-1047.
    PubMed     Abstract available
    
    
    
65. TANIUE K, Hayashi T, Kamoshida Y, Kurimoto A, et al
    UHRF1-KAT7-mediated regulation of TUSC3 expression via histone methylation/acetylation is critical for the proliferation of colon cancer cells.
    Oncogene. 2019 Oct 3. pii: 10.1038/s41388-019-1032.
    PubMed     Abstract available
    
    
    September 2019
66. WANG YN, Lu YX, Liu J, Jin Y, et al
    AMPKalpha1 confers survival advantage of colorectal cancer cells under metabolic stress by promoting redox balance through the regulation of glutathione reductase phosphorylation.
    Oncogene. 2019 Sep 17. pii: 10.1038/s41388-019-1004.
    PubMed     Abstract available
    
    
    
67. WEI TT, Lin YT, Tang SP, Luo CK, et al
    Metabolic targeting of HIF-1alpha potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer.
    Oncogene. 2019 Sep 2. pii: 10.1038/s41388-019-0999.
    PubMed     Abstract available
    
    
    
68. YANG S, Ren X, Liang Y, Yan Y, et al
    KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis.
    Oncogene. 2019 Sep 2. pii: 10.1038/s41388-019-0978.
    PubMed     Abstract available
    
    
    August 2019
69. HE Y, Davies CM, Harrington BS, Hellmers L, et al
    CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of beta-catenin and E-cadherin.
    Oncogene. 2019 Aug 30. pii: 10.1038/s41388-019-0983.
    PubMed     Abstract available
    
    
    
70. HYE PARK S, Jeong S, Ram Kim B, Jeong YA, et al
    Activating CCT2 triggers Gli-1 activation during hypoxic condition in colorectal cancer.
    Oncogene. 2019 Aug 28. pii: 10.1038/s41388-019-0972.
    PubMed     Abstract available
    
    
    
71. FENG D, Qin B, Pal K, Sun L, et al
    BRAF(V600E)-induced, tumor intrinsic PD-L1 can regulate chemotherapy-induced apoptosis in human colon cancer cells and in tumor xenografts.
    Oncogene. 2019 Aug 12. pii: 10.1038/s41388-019-0919.
    PubMed     Abstract available
    
    
    
72. BEYES S, Andrieux G, Schrempp M, Aicher D, et al
    Genome-wide mapping of DNA-binding sites identifies stemness-related genes as directly repressed targets of SNAIL1 in colorectal cancer cells.
    Oncogene. 2019 Aug 7. pii: 10.1038/s41388-019-0905.
    PubMed     Abstract available
    
    
    
73. BERG KCG, Sveen A, Holand M, Alagaratnam S, et al
    Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains.
    Oncogene. 2019;38:6109-6122.
    PubMed     Abstract available
    
    
    July 2019
74. HU YB, Yan C, Mu L, Mi YL, et al
    Correction: Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
    Oncogene. 2019 Jul 31. pii: 10.1038/s41388-019-0863.
    PubMed     Abstract available
    
    
    
75. CHEN D, Li Y, Zhang X, Wu H, et al
    Ubiquitin ligase TRIM65 promotes colorectal cancer metastasis by targeting ARHGAP35 for protein degradation.
    Oncogene. 2019 Jul 22. pii: 10.1038/s41388-019-0891.
    PubMed     Abstract available
    
    
    
76. CHEN Z, Ren R, Wan D, Wang Y, et al
    Hsa_circ_101555 functions as a competing endogenous RNA of miR-597-5p to promote colorectal cancer progression.
    Oncogene. 2019 Jul 12. pii: 10.1038/s41388-019-0857.
    PubMed     Abstract available
    
    
    
77. OHSUGI T, Yamaguchi K, Zhu C, Ikenoue T, et al
    Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/beta-catenin signaling in colorectal cancer cells.
    Oncogene. 2019 Jul 10. pii: 10.1038/s41388-019-0856.
    PubMed     Abstract available
    
    
    
78. ROHWER N, Jumpertz S, Erdem M, Egners A, et al
    Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis.
    Oncogene. 2019;38:5670-5685.
    PubMed     Abstract available
    
    
    June 2019
79. MISHRA S, Bernal C, Silvano M, Anand S, et al
    The protein secretion modulator TMED9 drives CNIH4/TGFalpha/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases.
    Oncogene. 2019 Jun 28. pii: 10.1038/s41388-019-0845.
    PubMed     Abstract available
    
    
    
80. JIANG M, Xu B, Li X, Shang Y, et al
    Correction: O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit.
    Oncogene. 2019 Jun 3. pii: 10.1038/s41388-019-0834.
    PubMed     Abstract available
    
    
    
81. GOWRIKUMAR S, Ahmad R, Uppada SB, Washington MK, et al
    Upregulated claudin-1 expression promotes colitis-associated cancer by promoting beta-catenin phosphorylation and activation in Notch/p-AKT-dependent manner.
    Oncogene. 2019;38:5321-5337.
    PubMed     Abstract available
    
    
    
82. SHORT SP, Barrett CW, Stengel KR, Revetta FL, et al
    Kaiso is required for MTG16-dependent effects on colitis-associated carcinoma.
    Oncogene. 2019;38:5091-5106.
    PubMed     Abstract available
    
    
    
83. SCHWIEBS A, Herrero San Juan M, Schmidt KG, Wiercinska E, et al
    Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase.
    Oncogene. 2019;38:4788-4803.
    PubMed     Abstract available
    
    
    May 2019
84. WAGNER S, Vlachogiannis G, De Haven Brandon A, Valenti M, et al
    Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.
    Oncogene. 2019 May 30. pii: 10.1038/s41388-019-0835.
    PubMed     Abstract available
    
    
    
85. LI M, Tang Y, Li Q, Xiao M, et al
    Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2.
    Oncogene. 2019;38:3488-3503.
    PubMed     Abstract available
    
    
    
86. YAMAZAKI D, Hasegawa A, Funato Y, Tran HN, et al
    Cnnm4 deficiency suppresses Ca(2+) signaling and promotes cell proliferation in the colon epithelia.
    Oncogene. 2019;38:3962-3969.
    PubMed     Abstract available
    
    
    April 2019
87. HAN Q, Xu L, Lin W, Yao X, et al
    Long noncoding RNA CRCMSL suppresses tumor invasive and metastasis in colorectal carcinoma through nucleocytoplasmic shuttling of HMGB2.
    Oncogene. 2019;38:3019-3032.
    PubMed     Abstract available
    
    
    March 2019
88. CLARKE PA, Roe T, Swabey K, Hobbs SM, et al
    Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer.
    Oncogene. 2019 Mar 25. pii: 10.1038/s41388-019-0780.
    PubMed     Abstract available
    
    
    
89. DE OLIVEIRA T, Ramakrishnan M, Diamanti MA, Ziegler PK, et al
    Loss of Stat6 affects chromatin condensation in intestinal epithelial cells causing diverse outcome in murine models of inflammation-associated and sporadic colon carcinogenesis.
    Oncogene. 2019;38:1787-1801.
    PubMed     Abstract available
    
    
    February 2019
90. WANG T, Song P, Zhong T, Wang X, et al
    The inflammatory cytokine IL-6 induces FRA1 deacetylation promoting colorectal cancer stem-like properties.
    Oncogene. 2019 Feb 25. pii: 10.1038/s41388-019-0763.
    PubMed     Abstract available
    
    
    
91. ZHAO GX, Xu YY, Weng SQ, Zhang S, et al
    CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation.
    Oncogene. 2019 Feb 11. pii: 10.1038/s41388-019-0740.
    PubMed     Abstract available
    
    
    
92. SONG ZY, Wang F, Cui SX, Gao ZH, et al
    CXCR7/CXCR4 heterodimer-induced histone demethylation: a new mechanism of colorectal tumorigenesis.
    Oncogene. 2019;38:1560-1575.
    PubMed     Abstract available
    
    
    
93. HUANG X, Wang XN, Yuan XD, Wu WY, et al
    XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation.
    Oncogene. 2019;38:1448-1460.
    PubMed     Abstract available
    
    
    
94. COBURN LA, Singh K, Asim M, Barry DP, et al
    Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis.
    Oncogene. 2019;38:1067-1079.
    PubMed     Abstract available
    
    
    
95. MUNOZ-GALVAN S, Lucena-Cacace A, Perez M, Otero-Albiol D, et al
    Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment.
    Oncogene. 2019;38:1309-1323.
    PubMed     Abstract available
    
    
    January 2019
96. KIM BR, Park SH, Jeong YA, Na YJ, et al
    RUNX3 enhances TRAIL-induced apoptosis by upregulating DR5 in colorectal cancer.
    Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0693.
    PubMed     Abstract available
    
    
    
97. GUHA P, Gardell J, Darpolor J, Cunetta M, et al
    STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells.
    Oncogene. 2019;38:533-548.
    PubMed     Abstract available
    
    
    
98. BAO Y, Guo Y, Yang Y, Wei X, et al
    PRSS8 suppresses colorectal carcinogenesis and metastasis.
    Oncogene. 2019;38:497-517.
    PubMed     Abstract available
    
    
    December 2018
99. WIESWEG M, Kasper S, Worm K, Herold T, et al
    Impact of RAS mutation subtype on clinical outcome-a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer.
    Oncogene. 2018 Dec 19. pii: 10.1038/s41388-018-0634.
    PubMed     Abstract available
    
    
    
100. CAUSSE SZ, Marcion G, Chanteloup G, Uyanik B, et al
     HSP110 translocates to the nucleus upon genotoxic chemotherapy and promotes DNA repair in colorectal cancer cells.
     Oncogene. 2018 Dec 12. pii: 10.1038/s41388-018-0616.
     PubMed     Abstract available
     
     
     
101. SUN Z, Ou C, Liu J, Chen C, et al
     YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer.
     Oncogene. 2018 Dec 10. pii: 10.1038/s41388-018-0628.
     PubMed     Abstract available
     
     
     November 2018
102. HU YB, Yan C, Mu L, Mi YL, et al
     Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
     Oncogene. 2018 Nov 2. pii: 10.1038/s41388-018-0557.
     PubMed     Abstract available
     
     
     
103. KOTELEVETS L, Walker F, Mamadou G, Lehy T, et al
     The Rac1 splice form Rac1b favors mouse colonic mucosa regeneration and contributes to intestinal cancer progression.
     Oncogene. 2018;37:6054-6068.
     PubMed     Abstract available
     
     
     
104. TAO Y, Liu Z, Hou Y, Wang S, et al
     Alternative NF-kappaB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3.
     Oncogene. 2018;37:5887-5900.
     PubMed     Abstract available
     
     
     October 2018
105. WAGNER S, Vlachogiannis G, De Haven Brandon A, Valenti M, et al
     Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.
     Oncogene. 2018 Oct 23. pii: 10.1038/s41388-018-0554.
     PubMed     Abstract available
     
     
     
106. WEI N, Li J, Fang C, Chang J, et al
     Targeting colon cancer with the novel STAT3 inhibitor bruceantinol.
     Oncogene. 2018 Oct 22. pii: 10.1038/s41388-018-0547.
     PubMed     Abstract available
     
     
     
107. SHIMIZU M, Tanaka N
     IL-8-induced O-GlcNAc modification via GLUT3 and GFAT regulates cancer stem cell-like properties in colon and lung cancer cells.
     Oncogene. 2018 Oct 10. pii: 10.1038/s41388-018-0533.
     PubMed     Abstract available
     
     
     September 2018
108. ARBEL RUBINSTEIN T, Shahmoon S, Zigmond E, Etan T, et al
     Klotho suppresses colorectal cancer through modulation of the unfolded protein response.
     Oncogene. 2018 Sep 19. pii: 10.1038/s41388-018-0489.
     PubMed     Abstract available
     
     
     
109. ZHAO L, Zhang D, Shen Q, Jin M, et al
     KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway.
     Oncogene. 2018 Sep 10. pii: 10.1038/s41388-018-0493.
     PubMed     Abstract available
     
     
     
110. NAKANO M, Kikushige Y, Miyawaki K, Kunisaki Y, et al
     Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer.
     Oncogene. 2018 Sep 4. pii: 10.1038/s41388-018-0480.
     PubMed     Abstract available
     
     
     August 2018
111. LI Q, Wei P, Wu J, Zhang M, et al
     The FOXC1/FBP1 signaling axis promotes colorectal cancer proliferation by enhancing the Warburg effect.
     Oncogene. 2018 Aug 31. pii: 10.1038/s41388-018-0469.
     PubMed     Abstract available
     
     
     
112. JIANG M, Xu B, Li X, Shang Y, et al
     O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit.
     Oncogene. 2018 Aug 9. pii: 10.1038/s41388-018-0435.
     PubMed     Abstract available
     
     
     
113. HE F, Song Z, Chen H, Chen Z, et al
     Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128.
     Oncogene. 2018 Aug 3. pii: 10.1038/s41388-018-0432.
     PubMed     Abstract available
     
     
     
114. LEE HK, Lee EW, Seo J, Jeong M, et al
     Ubiquitylation and degradation of adenomatous polyposis coli by MKRN1 enhances Wnt/beta-catenin signaling.
     Oncogene. 2018;37:4273-4286.
     PubMed     Abstract available
     
     
     July 2018
115. WANG YN, Zeng ZL, Lu J, Wang Y, et al
     CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis.
     Oncogene. 2018 Jul 11. pii: 10.1038/s41388-018-0384.
     PubMed     Abstract available
     
     
     June 2018
116. ZENG K, Chen X, Hu X, Liu X, et al
     LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
     Oncogene. 2018 Jun 13. pii: 10.1038/s41388-018-0352.
     PubMed     Abstract available
     
     
     
117. LEE H, Kim N, Yoo YJ, Kim H, et al
     beta-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer.
     Oncogene. 2018 Jun 12. pii: 10.1038/s41388-018-0362.
     PubMed     Abstract available
     
     
     
118. LIU J, Zhang Z, Li X, Chen J, et al
     Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression.
     Oncogene. 2018 Jun 8. pii: 10.1038/s41388-018-0355.
     PubMed     Abstract available
     
     
     
119. DANKNER M, Rose AAN, Rajkumar S, Siegel PM, et al
     Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations.
     Oncogene. 2018;37:3183-3199.
     PubMed     Abstract available
     
     
     May 2018
120. KNICKELBEIN K, Tong J, Chen D, Wang YJ, et al
     Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer.
     Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0289.
     PubMed     Abstract available
     
     
     April 2018
121. COANT N, Garcia-Barros M, Zhang Q, Obeid LM, et al
     AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells.
     Oncogene. 2018 Apr 17. pii: 10.1038/s41388-018-0236.
     PubMed     Abstract available
     
     
     
122. JUNG JH, Jung DB, Kim H, Lee H, et al
     Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3beta and F-box and WD repeat domain-containing 7.
     Oncogene. 2018 Apr 9. pii: 10.1038/s41388-018-0225.
     PubMed     Abstract available
     
     
     March 2018
123. ZHANG Y, Wang S, Kang W, Liu C, et al
     CREPT facilitates colorectal cancer growth through inducing Wnt/beta-catenin pathway by enhancing p300-mediated beta-catenin acetylation.
     Oncogene. 2018 Mar 22. pii: 10.1038/s41388-018-0161.
     PubMed     Abstract available
     
     
     
124. CHU PC, Lin PC, Wu HY, Lin KT, et al
     Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
     Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0222.
     PubMed     Abstract available
     
     
     
125. SAPONARO C, Sergio S, Coluccia A, De Luca M, et al
     beta-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy.
     Oncogene. 2018 Mar 19. pii: 10.1038/s41388-018-0170.
     PubMed     Abstract available
     
     
     
126. TANG J, Chen H, Wong CC, Liu D, et al
     DEAD-box helicase 27 promotes colorectal cancer growth and metastasis and predicts poor survival in CRC patients.
     Oncogene. 2018 Mar 14. pii: 10.1038/s41388-018-0196.
     PubMed     Abstract available
     
     
     
127. YANG JB, Zhao ZB, Liu QZ, Hu TD, et al
     FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages.
     Oncogene. 2018;37:1192-1204.
     PubMed     Abstract available
     
     
     February 2018
128. ROMANO G, Chagani S, Kwong LN
     The path to metastatic mouse models of colorectal cancer.
     Oncogene. 2018 Feb 21. pii: 10.1038/s41388-018-0155.
     PubMed     Abstract available
     
     
     
129. CUYAS E, Fernandez-Arroyo S, Verdura S, Garcia RA, et al
     Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism.
     Oncogene. 2018;37:963-970.
     PubMed     Abstract available
     
     
     
130. DI RUOCCO F, Basso V, Rivoire M, Mehlen P, et al
     Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression.
     Oncogene. 2018;37:627-637.
     PubMed     Abstract available
     
     
     January 2018
131. SHEN L, Qu X, Li H, Xu C, et al
     NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis.
     Oncogene. 2018 Jan 18. pii: 10.1038/s41388-017-0118.
     PubMed     Abstract available
     
     
     
132. SOLOMON H, Dinowitz N, Pateras IS, Cooks T, et al
     Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
     Oncogene. 2018 Jan 18. pii: 10.1038/s41388-017-0060.
     PubMed     Abstract available
     
     
     
133. HERR R, Halbach S, Heizmann M, Busch H, et al
     BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines.
     Oncogene. 2018 Jan 12. pii: 10.1038/s41388-017-0063.
     PubMed     Abstract available
     
     
     
134. LIU L, Luo C, Luo Y, Chen L, et al
     MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression.
     Oncogene. 2018;37:86-94.
     PubMed     Abstract available
     
     
     
135. CHANDRASINGHE P, Cereser B, Moorghen M, Al Bakir I, et al
     Role of SMAD proteins in colitis-associated cancer: from known to the unknown.
     Oncogene. 2018;37:1-7.
     PubMed     Abstract available
     
     
     
136. SONG C, Liang L, Jin Y, Li Y, et al
     RCC2 is a novel p53 target in suppressing metastasis.
     Oncogene. 2018;37:8-17.
     PubMed     Abstract available
     
     
     
137. DIEHL K, Dinges LA, Helm O, Ammar N, et al
     Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.
     Oncogene. 2018;37:39-51.
     PubMed     Abstract available
     
     
     December 2017
138. OMOTO T, Kim-Kaneyama JR, Lei XF, Orimo A, et al
     The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodeling.
     Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0033.
     PubMed     Abstract available
     
     
     
139. BLOMME A, Van Simaeys G, Doumont G, Costanza B, et al
     Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases.
     Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0018.
     PubMed     Abstract available
     
     
     
140. LEE SH, Yu J, Hwang GH, Kim S, et al
     CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR.
     Oncogene. 2017;36:6823-6829.
     PubMed     Abstract available
     
     
     November 2017
141. HATA AN, Rowley S, Archibald HL, Gomez-Caraballo M, et al
     Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers.
     Oncogene. 2017;36:6581-6591.
     PubMed     Abstract available
     
     
     
142. LEE JH, Han YS, Yoon YM, Yun CW, et al
     Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1alpha/GP78 axis.
     Oncogene. 2017;36:6555-6567.
     PubMed     Abstract available
     
     
     
143. WANG Q, Zhu J, Wang YW, Dai Y, et al
     Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma.
     Oncogene. 2017;36:6225-6234.
     PubMed     Abstract available
     
     
     
144. TRINIDAD AG, Whalley N, Rowlinson R, Delpuech O, et al
     Pyruvate dehydrogenase kinase 4 exhibits a novel role in the activation of mutant KRAS, regulating cell growth in lung and colorectal tumour cells.
     Oncogene. 2017;36:6164-6176.
     PubMed     Abstract available
     
     
     October 2017
145. SCHROYER AL, Stimes NW, Abi Saab WF, Chadee DN, et al
     MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells.
     Oncogene. 2017 Oct 30. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
146. BENTHANI FA, Herrmann D, Tran PN, Pangon L, et al
     'MCC' protein interacts with E-cadherin and beta-catenin strengthening cell-cell adhesion of HCT116 colon cancer cells.
     Oncogene. 2017 Oct 16. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
147. WEISENBERGER DJ, Liang G, Lenz HJ
     DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
     Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
148. WANG LF, Liu YS, Yang B, Li P, et al
     The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.
     Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     September 2017
149. FU LN, Wang YQ, Tan J, Xu J, et al
     Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms.
     Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     
150. LIU L, Wong CC, Gong B, Yu J, et al
     Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
     Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
     PubMed     Abstract available
     
     
     August 2017
151. WANG X, Haring MF, Rathjen T, Lockhart SM, et al
     Insulin resistance in vascular endothelial cells promotes intestinal tumour formation.
     Oncogene. 2017;36:4987-4996.
     PubMed     Abstract available
     
     
     
152. HANLEY MP, Hahn MA, Li AX, Wu X, et al
     Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia.
     Oncogene. 2017;36:5035-5044.
     PubMed     Abstract available
     
     
     
153. SUMNER ET, Chawla AT, Cororaton AD, Koblinski JE, et al
     Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia.
     Oncogene. 2017;36:4810-4816.
     PubMed     Abstract available
     
     
     July 2017
154. MA X, Meng Z, Jin L, Xiao Z, et al
     CAMK2gamma in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation.
     Oncogene. 2017;36:4060-4071.
     PubMed     Abstract available
     
     
     
155. HARDBOWER DM, Coburn LA, Asim M, Singh K, et al
     EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis.
     Oncogene. 2017;36:3807-3819.
     PubMed     Abstract available
     
     
     June 2017
156. LI Y, Zhou T, Wang Y, Ning C, et al
     The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation.
     Oncogene. 2017;36:3760-3771.
     PubMed     Abstract available
     
     
     
157. ROS S, Floter J, Kaymak I, Da Costa C, et al
     6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.
     Oncogene. 2017;36:3287-3299.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: